2016 - Volume 1 - Issue 1 Articles
-
Editorial | ArticleApril 20, 2016 | Pages : 205 - 450Abstract The introduction of NAs for oral antiviral therapy has dramatically improved the clinical outcome in patients with CHB due to their ability to inhibit viral replication [1]. ?owever, HBV eradication and the ideal goal of HBsAg loss is rarely me.....
-
Editorial | ArticleApril 21, 2016 | Pages : 205 - 450Abstract Nonalcoholic fatty liver disease (NAFLD) is increasingly worldwide and is the most common chronic liver disease observed in clinical practice, affecting approximately one-third of general population and up 70% of patients with Type 2 diabetes [.....
-
Editorial | ArticleMay 18, 2016 | Pages : 205 - 450Abstract The cytokine interleukin-33 (IL-33) is a member of IL-1 family described in 2005 with pluripotent functions in various diseases and wide spectrum of target immune cells in tissues [1]. In human, IL-33 is encoded on chromosome 9 and full length .....
-
Review Article | ArticleAugust 01, 2016 | Pages : 205 - 450Abstract Around 250 million persons are chronically infected with hepatitis B virus (HBV) worldwide, and this infection may lead to cirrhosis and Hepatocellular carcinoma (HCC). HBV can circulate as an occult infection (OBI), with the absence of the classical.....
-
Review Article | ArticleBy Qianni ChengSeptember 22, 2016 | Pages : 205 - 450Abstract Insulin resistance and hyperglycemia in type 2 diabetes mellitus (T2DM) are both correlated with hepatitis and hepatocyte carcinoma. Thiazolidinediones and biguanides, belong to insulin sensitizers, are front-line antidiabetic drugs. DPP-4 inhibitors.....